Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Dr. Luskin received her MD from the University of Pennsylvania Perelman School of Medicine in 2009. She completed residency training in Internal Medicine at Brigham and Women's Hospital and served as Chief Medical Resident in 2015. She completed her fellowship in Hematology and Oncology at the University of Pennsylvania where she also earned her Masters degree in clinical epidemiology and served as Chief Fellow. She joined Dana-Farber as a member of the Adult Leukemia program in 2016 where she focuses on the care of patients with acute and chronic leukemias with particular areas of interest including acute lymphoblastic leukemia, acute myeloid leukemia, chronic myeloid leukemia, blastic plasmacytoid dendritic cell neoplasm, and the care of young adults with acute and chronic leukemias. Dr. Luskin is also active in leading clinical trials and serves as the associate program director of the Dana-Farber/Mass General Brigham Hematology/Oncology Fellowship Program and education director for the adult leukemia program.
Marlise Luskin, MD, MSCE, is a physician in Dana-Farber’s Adult Leukemia program. She treats patients with acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), myelodysplastic syndrome and a number of other blood cancers. Luskin discusses her approach to a patient’s first visit, and helping patients understand their disease and treatment options. Learn more about the leukemia program: http://www.dana-farber.org/adult-leukemia-program/
Dana-Farber Cancer Institute450 Brookline AvenueBoston, MA 02215Get Directions